Main Outcome Measures
Abbreviations and Acronyms:CFI (capillary flux index), CI (confidence interval), CPD (capillary perfusion density), OCTA (OCT angiography), PD (Parkinson’s disease), RNFL (retinal nerve fiber layer), RPC (radial peripapillary capillary)
- Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.Nat Rev Neurosci. 2002; 3: 932-942
- Non-motor symptoms of Parkinson's disease: diagnosis and management.Lancet Neurol. 2006; 5: 235-245
- The retina in Parkinson's disease.Brain. 2009; 132: 1128-1145
- Visual symptoms in Parkinson's disease.Parkinsons Dis. 2011; 2011: 908306
- Seeing ophthalmologic problems in Parkinson disease: results of a visual impairment questionnaire.Neurology. 2020; 94: 1539-1547
- Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.Invest Ophthalmol Vis Sci. 2014; 55: 696-705
- Correlation between structural and functional retinal changes in Parkinson disease.J Neuroophthalmol. 2015; 35: 254-258
- Decreased dopamine in the retinas of patients with Parkinson's disease.Invest Ophthalmol Vis Sci. 1990; 31: 2473-2475
- Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.Mov Disord. 2018; 33: 1315-1324
- The retina as a window to the brain-from eye research to CNS disorders.Nat Rev Neurol. 2013; 9: 44-53
- Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration.Am J Ophthalmol. 2014; 157: 470-478
- Retinal nerve fiber layer thickness in Parkinson disease.J Neuroophthalmology. 2013; 33: 62-65
- Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.Mov Disord. 2014; 29: 61-67
- Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.Eur J Ophthalmol. 2011; 21: 24-29
- In vivo morphology of the optic nerve and retina in patients with Parkinson's disease.Invest Ophthalmol Vis Sci. 2016; 57: 4420-4427
- Retinal thinning and correlation with functional disability in patients with Parkinson's disease.Br J Ophthalmol. 2014; 98: 350-355
- Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis.PLoS One. 2014; 9: 85718
- Inner retinal layer thinning in Parkinson disease.Arch Ophthalmol. 2009; 127: 737-741
- Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.Ophthalmology. 2012; 119: 2161-2167
- Retinal microvascular and neurodegenerative changes in Alzheimer's disease and mild cognitive impairment compared with control participants.Ophthalmol Retina. 2019; 3: 489-499
- In vivo characterization of retinal microvascular network in multiple sclerosis.Ophthalmology. 2016; 123: 437-438
- Retinal microvascular impairment in the early stages of Parkinson's disease.Invest Ophthalmol Vis Sci. 2018; 59: 4115-4122
- Characterization by fractal dimension analysis of the retinal capillary network in Parkinson disease.Retina. 2020; 40: 1483-1491
- Characterization of retinal microvascular and choroidal structural changes in Parkinson disease.JAMA Ophthalmol. 2020; e205730
- Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography.Sci Rep. 2017; 7: 42201
- MDS clinical diagnostic criteria for Parkinson's disease.Mov Disord. 2015; 30: 1591-1601
- Validation of the MDS clinical diagnostic criteria for Parkinson's disease.Mov Disord. 2018; 33: 1601-1608
- ZEISS Angioplex spectral domain optical coherence tomography angiography: technical aspects.Dev Ophthalmol. 2016; 56: 18-29
- Parkinsonism: onset, progression and mortality.Neurology. 1967; 17: 427-442
- Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.Mov Disord. 2004; 19: 1020-1028
Zeiss CIRRUS HD-OCT 5000 User Manual. 2660021169012 Rev. A 2017-12. Carl Zeiss Meditec. Retrieved from https://www.zeiss.co.uk/content/dam/Meditec/gb/Chris/Refractive-Business-Builder/2018Updates/UserGuides/oct_usermanual.pdf. Accessed May 1, 2020.
- Radial peripapillary capillaries of the retina. I. Anatomy: human and comparative.Br J Ophthalmol. 1967; 51: 115-123
- Correlation between the radial peripapillary capillaries and the retinal nerve fibre layer in the normal human retina.Exp Eye Res. 2014; 129: 83-92
- Effect of scan size on glaucoma diagnostic performance using OCT angiography en face images of the radial peripapillary capillaries.J Glaucoma. 2019; 28: 465-472
- Prevalence and severity of artifacts in optical coherence tomographic angiograms.JAMA Ophthalmol. 2019; 138: 119-126
- Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern?.Eur J Neurol. 2012; 20: 198-201
- Neural-vascular relationships in central retina of macaque monkeys (Macaca fascicularis).J Neurosci. 1992; 12: 1169-1193
- Vascular dysfunction in Alzheimer’s disease: a prelude to the pathological process or a consequence of it?.J Clin Med. 2019; 8: 651
- String vessel formation is increased in the brain of Parkinson disease.J Parkinson Dis. 2015; 5: 821-836
- Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer’s disease.PLoS One. 2012; 7e36893
- Effects of levodopa on regional cerebral metabolism and blood flow.Mov Disord. 2015; 30: 54-63
- Effects of levodopa on retina in Parkinson disease.Eur J Ophthalmol. 2014; 24: 114-119
- Levodopa positively affects neovascular age-related macular degeneration.Am J Med. 2021; 134 (e3): 122-128
Robbins CB, Grewal DS, Thompson AC, et al. Repeatability of peripapillary optical coherence tomography angiography parameters in older adults. J Vitreoretin Dis. Published online ahead of print. https://doi.org/10.1177/2474126420953968.
Publication stageIn Press Journal Pre-Proof
Supplemental material available at www.ophthalmologyretina.org.
Disclosure(s): All authors have completed and submitted the ICMJE disclosures form. The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Presented at: the 2020 North Carolina Society for Eye Physicians and Surgeons Annual Meeting, Greensboro, North Carolina, September 19, 2020.
Conception and design: Robbins, Grewal, Fekrat
Data collection: Robbins, Grewal, Thompson, Soundararajan, Yoon, Polascik, Scott, Fekrat
Analysis and interpretation: Robbins, Thompson, Grewal, Fekrat
Obtained funding: N/A
Overall responsibility: Robbins, Grewal, Fekrat
HUMAN SUBJECTS: Human subjects were included in this study. The human ethics committees at Duke Health approved the study. All research adhered to the tenets of the Declaration of Helsinki. All participants provided informed consent.
No animal subjects were included in this study.